Cellular signaling was represented by pathways that drive proliferation in ER+ and ERBB2+ cancer cells (e.g., MAPK, EGFR/ERBB2 and estrogen signaling), and additional downstream pathways involved in proliferation, apoptosis and survival. This evidence concerns the gene EGFR and cancer.